Express Scripts Holding Company (NASDAQ:ESRX) – Analysts at Jefferies Group upped their FY2017 earnings estimates for Express Scripts in a report released on Friday. Jefferies Group analyst B. Tanquilut now anticipates that the company will post earnings of $7.04 per share for the year, up from their previous forecast of $7.02. Jefferies Group currently has a “Buy” rating and a $80.00 price target on the stock. Jefferies Group also issued estimates for Express Scripts’ Q4 2017 earnings at $2.08 EPS, Q1 2018 earnings at $1.48 EPS, Q2 2018 earnings at $1.88 EPS, Q3 2018 earnings at $2.10 EPS, Q4 2018 earnings at $2.30 EPS and FY2018 earnings at $7.77 EPS.
Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting analysts’ consensus estimates of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. During the same period last year, the company posted $1.74 EPS. The business’s revenue was down 2.9% on a year-over-year basis.
Express Scripts (NASDAQ:ESRX) opened at $73.66 on Monday. Express Scripts has a 52 week low of $55.80 and a 52 week high of $74.67. The company has a market cap of $41,560.45, a price-to-earnings ratio of 10.73, a price-to-earnings-growth ratio of 1.08 and a beta of 0.88. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86.
In related news, VP Phyllis S. Anderson sold 643 shares of Express Scripts stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Christine Houston sold 10,104 shares of Express Scripts stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now owns 87,400 shares of the company’s stock, valued at approximately $6,124,992. The disclosure for this sale can be found here. Company insiders own 0.68% of the company’s stock.
Large investors have recently bought and sold shares of the company. Burt Wealth Advisors raised its holdings in shares of Express Scripts by 11.4% in the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after purchasing an additional 174 shares in the last quarter. CKW Financial Group raised its holdings in shares of Express Scripts by 20.0% in the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock valued at $115,000 after purchasing an additional 300 shares in the last quarter. Bank of Nova Scotia Trust Co. bought a new position in shares of Express Scripts during the 3rd quarter worth approximately $120,000. First Personal Financial Services raised its stake in shares of Express Scripts by 199.1% during the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after acquiring an additional 1,400 shares in the last quarter. Finally, Monroe Bank & Trust MI raised its stake in shares of Express Scripts by 74.8% during the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after acquiring an additional 970 shares in the last quarter. Institutional investors and hedge funds own 88.28% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Jefferies Group Brokers Increase Earnings Estimates for Express Scripts Holding Company (ESRX)” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://sportsperspectives.com/2017/12/20/jefferies-group-brokers-increase-earnings-estimates-for-express-scripts-holding-company-esrx.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.